Showing results (1-10 of 135) with videos related to
Sort By:
Pageof 14
International Journal of the Economics of Business|October 12, 2020
FOUR FACTS CONCERNING COMPETITION IN U.S. GENERIC PRESCRIPTION DRUG MARKETSRena M Conti, Ernst R BerndtJournal of Law and the Biosciences|May 1, 2018
The generic drug user fee amendments: an economic perspectiveErnst R Berndt, Rena M Conti, Stephen J MurphyJournal of Law and the Biosciences|May 14, 2021
The geography of prescription pharmaceuticals supplied to the USA: levels, trends, and implicationsYashna Shivdasani, Neriman Beste Kaygisiz, Ernst R Berndt, et al.Medical Care|April 23, 2013
The impact of emerging safety and effectiveness evidence on the use of physician-administered drugs: the case of bevacizumab for breast cancerRena M Conti, Stacie B Dusetzina, Ann C Herbert, et al.Pharmacoeconomics|January 22, 2005
Changes in the costs of treating mental health disorders: an overview of recent research findingsErnst R BerndtHealth Affairs (Project Hope)|March 9, 2004
Unique issues raised by drug benefit designErnst R BerndtDrug Discovery Today|November 7, 2015
The clinical benefits, ethics, and economics of stratified medicine and companion diagnosticsMark R Trusheim, Ernst R BerndtPsychopharmacology Bulletin|December 20, 2002
Depression treatment: a lifelong commitment?Martin B Keller, Ernst R BerndtHealth Affairs (Project Hope)|May 12, 2005
Vaccine advance-purchase agreements for low-income countries: practical issuesErnst R Berndt, John A HurvitzPersonalized Medicine|May 20, 2018
Economic challenges and possible policy actions to advance stratified medicineMark R Trusheim, Ernst R BerndtPageof 14